Skip to main content
Clinical Trials/ISRCTN34963223
ISRCTN34963223
Active, not recruiting
未知

Evaluation of oxygen saturation and serum levels of growth hormone and bone growth mediators after rapid maxillary expansion in growing patients

niversity of Alberta0 sites120 target enrollmentMay 31, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Alberta
Enrollment
120
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 31, 2023
End Date
December 24, 2025
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Alberta

Eligibility Criteria

Inclusion Criteria

  • 1\. Good general health according to medical history and clinical examination
  • 2\. Maxillary transverse discrepancy (skeletal discrepancy) with or without unilateral posterior crossbite
  • 3\. Age between 7 and 10 years old (this age range was chosen to prevent bias in terms of pubertal peak growth since at this age it is assumed males and females have not had it yet)
  • 4\. Body mass index (BMI) is healthy (not below the 25th percentile and not above the 75th percentile) according to age.

Exclusion Criteria

  • Patients in the pubertal growth spurt

Outcomes

Primary Outcomes

Not specified

Similar Trials